Cargando…

Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009

INTRODUCTION: Multimorbidity, the presence of 2 or more chronic conditions, frequently affects people with chronic obstructive pulmonary disease (COPD). Many have high-cost, highly complex conditions that have a substantial impact on state Medicaid programs. We quantified the cost of Medicaid-insure...

Descripción completa

Detalles Bibliográficos
Autores principales: Westney, Gloria, Foreman, Marilyn G., Xu, Junjun, Henriques King, Marshaleen, Flenaugh, Eric, Rust, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392445/
https://www.ncbi.nlm.nih.gov/pubmed/28409741
http://dx.doi.org/10.5888/pcd14.160333
_version_ 1783229444160225280
author Westney, Gloria
Foreman, Marilyn G.
Xu, Junjun
Henriques King, Marshaleen
Flenaugh, Eric
Rust, George
author_facet Westney, Gloria
Foreman, Marilyn G.
Xu, Junjun
Henriques King, Marshaleen
Flenaugh, Eric
Rust, George
author_sort Westney, Gloria
collection PubMed
description INTRODUCTION: Multimorbidity, the presence of 2 or more chronic conditions, frequently affects people with chronic obstructive pulmonary disease (COPD). Many have high-cost, highly complex conditions that have a substantial impact on state Medicaid programs. We quantified the cost of Medicaid-insured patients with COPD co-diagnosed with other chronic disorders. METHODS: We used nationally representative Medicaid claims data to analyze the impact of comorbidities (other chronic conditions) on the disease burden, emergency department (ED) use, hospitalizations, and total health care costs among 291,978 adult COPD patients. We measured the prevalence of common conditions and their influence on COPD-related and non–COPD-related resource use by using the Elixhauser Comorbidity Index. Elixhauser comorbidity counts were clustered from 0 to 7 or more. We performed multivariable logistic regression to determine the odds of ED visits by Elixhauser scores adjusting for age, sex, race/ethnicity, and residence. RESULTS: Acute care, hospital bed days, and total Medicaid-reimbursed costs increased as the number of comorbidities increased. ED visits unrelated to COPD were more common than visits for COPD, especially in patients self-identified as black or African American (designated black). Hypertension, diabetes, affective disorders, hyperlipidemia, and asthma were the most prevalent comorbid disorders. Substance abuse, congestive heart failure, and asthma were commonly associated with ED visits for COPD. Female sex was associated with COPD-related and non–COPD-related ED visits. CONCLUSION: Comorbidities markedly increased health services use among people with COPD insured with Medicaid, although ED visits in this study were predominantly unrelated to COPD. Achieving excellence in clinical practice with optimal clinical and economic outcomes requires a whole-person approach to the patient and a multidisciplinary health care team.
format Online
Article
Text
id pubmed-5392445
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-53924452017-05-01 Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009 Westney, Gloria Foreman, Marilyn G. Xu, Junjun Henriques King, Marshaleen Flenaugh, Eric Rust, George Prev Chronic Dis Original Research INTRODUCTION: Multimorbidity, the presence of 2 or more chronic conditions, frequently affects people with chronic obstructive pulmonary disease (COPD). Many have high-cost, highly complex conditions that have a substantial impact on state Medicaid programs. We quantified the cost of Medicaid-insured patients with COPD co-diagnosed with other chronic disorders. METHODS: We used nationally representative Medicaid claims data to analyze the impact of comorbidities (other chronic conditions) on the disease burden, emergency department (ED) use, hospitalizations, and total health care costs among 291,978 adult COPD patients. We measured the prevalence of common conditions and their influence on COPD-related and non–COPD-related resource use by using the Elixhauser Comorbidity Index. Elixhauser comorbidity counts were clustered from 0 to 7 or more. We performed multivariable logistic regression to determine the odds of ED visits by Elixhauser scores adjusting for age, sex, race/ethnicity, and residence. RESULTS: Acute care, hospital bed days, and total Medicaid-reimbursed costs increased as the number of comorbidities increased. ED visits unrelated to COPD were more common than visits for COPD, especially in patients self-identified as black or African American (designated black). Hypertension, diabetes, affective disorders, hyperlipidemia, and asthma were the most prevalent comorbid disorders. Substance abuse, congestive heart failure, and asthma were commonly associated with ED visits for COPD. Female sex was associated with COPD-related and non–COPD-related ED visits. CONCLUSION: Comorbidities markedly increased health services use among people with COPD insured with Medicaid, although ED visits in this study were predominantly unrelated to COPD. Achieving excellence in clinical practice with optimal clinical and economic outcomes requires a whole-person approach to the patient and a multidisciplinary health care team. Centers for Disease Control and Prevention 2017-04-13 /pmc/articles/PMC5392445/ /pubmed/28409741 http://dx.doi.org/10.5888/pcd14.160333 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Original Research
Westney, Gloria
Foreman, Marilyn G.
Xu, Junjun
Henriques King, Marshaleen
Flenaugh, Eric
Rust, George
Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009
title Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009
title_full Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009
title_fullStr Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009
title_full_unstemmed Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009
title_short Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009
title_sort impact of comorbidities among medicaid enrollees with chronic obstructive pulmonary disease, united states, 2009
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392445/
https://www.ncbi.nlm.nih.gov/pubmed/28409741
http://dx.doi.org/10.5888/pcd14.160333
work_keys_str_mv AT westneygloria impactofcomorbiditiesamongmedicaidenrolleeswithchronicobstructivepulmonarydiseaseunitedstates2009
AT foremanmarilyng impactofcomorbiditiesamongmedicaidenrolleeswithchronicobstructivepulmonarydiseaseunitedstates2009
AT xujunjun impactofcomorbiditiesamongmedicaidenrolleeswithchronicobstructivepulmonarydiseaseunitedstates2009
AT henriqueskingmarshaleen impactofcomorbiditiesamongmedicaidenrolleeswithchronicobstructivepulmonarydiseaseunitedstates2009
AT flenaugheric impactofcomorbiditiesamongmedicaidenrolleeswithchronicobstructivepulmonarydiseaseunitedstates2009
AT rustgeorge impactofcomorbiditiesamongmedicaidenrolleeswithchronicobstructivepulmonarydiseaseunitedstates2009